Cargando…
Lncrna FEZf1-as1 negatively regulates ETNK1 to promote malignant progression of renal cell carcinoma
BACKGROUND: To explore the role of LncFEZF1-AS1 in renal cell carcinoma (RCC) tissues and cells, and the possible molecular mechanism. METHODS: Expressions of LncFEZF1-AS1 in RCC tissues and adjacent ones were detected. The association of LncFEZF1-AS1 level with clinical data of RCC patients was als...
Autores principales: | Lou, Jiangyong, Liu, Xiaoming, Fan, Xiaodong, Xu, Xiaoming, Wang, Zhichao, Wang, Liqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society of Medical Biochemists of Serbia, Belgrade
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040190/ https://www.ncbi.nlm.nih.gov/pubmed/36987411 http://dx.doi.org/10.5937/jomb0-39710 |
Ejemplares similares
-
FEZF1-AS1 functions as an oncogenic lncRNA in retinoblastoma
por: Quan, Lian-Jiao, et al.
Publicado: (2019) -
FEZF1-AS1: a novel vital oncogenic lncRNA in multiple human malignancies
por: Shi, Changlong, et al.
Publicado: (2019) -
miR-708–3p promotes gastric cancer progression through downregulating ETNK1
por: Shang, Jincai, et al.
Publicado: (2023) -
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine
por: Fontana, Diletta, et al.
Publicado: (2020) -
The ETNK2 gene promotes progression of papillary thyroid carcinoma through the HIPPO pathway
por: Zheng, Danni, et al.
Publicado: (2022)